← Leaderboards
Keoki Williams
Henry Ford Health System
$18,740,627
Attributed
$18,965,351
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,965,351 · 9
By mechanism
R01$18,065,904 · 7
R56$449,999 · 1
R21$449,448 · 1
Top collaborators
- David E Lanfear2 shared
Most similar at Henry Ford Health System
Same institution · by research overlap
- Dennis R Ownby$4,912,300
- Andrea E Cassidy-Bushrow$6,967,230
- Manel Pladevall$2,027,493
Others in their field
Top investigators on “Cohort”
- David R. Weir · University Of Michigan At Ann Arbor$406,814,098
- George R Seage · Abt Associates, Inc.$297,656,361
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$242,146,554
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417
- Lawrence Corey · Fred Hutchinson Cancer Center$227,738,417
- James Dennis Neaton · Northwestern University$203,539,316
Research focus
CohortAfrican AmericanCessation Of LifeGenome Wide Association StudyGeneticPharmaceutical PreparationsAsthmaGenesHospitalizationPrevalencePharmacogenomicsAdmixtureEventEuropeanSamplingVariantAmericanGenotypePopulation GroupPhenotypePreventRaceClinical DataPatient Population
Grant awards (33)
Development of Polygenic Scores for Medication Response in Diverse Populations$202,672
R21 · FY2025 · HL
Development of Polygenic Scores for Medication Response in Diverse Populations$246,776
R21 · FY2024 · HL
Poly-omic Study of Asthma Exacerbations in Diverse Populations$739,482
R01 · FY2022 · HL · contact PI
High-resolution characterization of human leukocyte antigen genes in diverse populations to study the genetics of food allergy$449,999
R56 · FY2022 · AI · contact PI
Poly-omic Study of Asthma Exacerbations in Diverse Populations$744,821
R01 · FY2021 · HL · contact PI
Leveraging electronic medical records to perform large-scale diabetes pharmacogenomics among ancestrally diverse patient populations$605,577
R01 · FY2021 · DK · contact PI
Poly-omic Study of Asthma Exacerbations in Diverse Populations$759,214
R01 · FY2020 · HL · contact PI
Leveraging electronic medical records to perform large-scale diabetes pharmacogenomics among ancestrally diverse patient populations$635,940
R01 · FY2020 · DK · contact PI
Poly-omic Study of Asthma Exacerbations in Diverse Populations$797,921
R01 · FY2019 · HL · contact PI
Leveraging electronic medical records to perform large-scale diabetes pharmacogenomics among ancestrally diverse patient populations$640,328
R01 · FY2019 · DK · contact PI
Leveraging electronic medical records to perform large-scale diabetes pharmacogenomics among ancestrally diverse patient populations$643,378
R01 · FY2018 · DK · contact PI
Combined Transcriptomics and Genomics to Find Asthma Genes in Admixed Populations$712,914
R01 · FY2017 · HL · contact PI
Leveraging electronic medical records to perform large-scale diabetes pharmacogenomics among ancestrally diverse patient populations$642,048
R01 · FY2017 · DK · contact PI
Combined Transcriptomics and Genomics to Find Asthma Genes in Admixed Populations$727,533
R01 · FY2016 · HL · contact PI
Combined Transcriptomics and Genomics to Find Asthma Genes in Admixed Populations$718,345
R01 · FY2015 · HL · contact PI
Combined Transcriptomics and Genomics to Find Asthma Genes in Admixed Populations$741,390
R01 · FY2014 · HL · contact PI
PHARMACOGENOMICS OF INHALED CORTICOSTEROID RESPONSIVENESS IN PATIENTS WITH ASTHMA$668,904
R01 · FY2013 · AI · contact PI
PHARMACOGENOMICS OF INHALED CORTICOSTEROID RESPONSIVENESS IN PATIENTS WITH ASTHMA$708,467
R01 · FY2012 · AI · contact PI
PHARMACOGENOMICS OF INHALED CORTICOSTEROID RESPONSIVENESS IN PATIENTS WITH ASTHMA$712,955
R01 · FY2011 · AI · contact PI
PHARMACOGENOMICS OF INHALED CORTICOSTEROID RESPONSIVENESS IN PATIENTS WITH ASTHMA$732,635
R01 · FY2010 · AI · contact PI
The Clinical Effectiveness of Pharmacy Adherence Information for Diabetes Control$317,165
R01 · FY2010 · DK · contact PI
PHARMACOGENOMICS OF INHALED CORTICOSTEROID RESPONSIVENESS IN PATIENTS WITH ASTHMA$723,765
R01 · FY2009 · AI · contact PI
PHARMACOGENOMICS OF INHALED CORTICOSTEROID RESPONSIVENESS IN PATIENTS WITH ASTHMA$401,576
R01 · FY2009 · AI · contact PI
The Clinical Effectiveness of Pharmacy Adherence Information for Diabetes Control$369,246
R01 · FY2009 · DK · contact PI
Mechanism of Endotoxin's Effect On Allergy Risk$569,961
R01 · FY2008 · AI · contact PI
USING INFORMATION TECHNOLOGY TO IMPROVE ASTHMA ADHERENCE$339,139
R01 · FY2008 · HL · contact PI
Mechanism of Endotoxin's Effect On Allergy Risk$652,896
R01 · FY2007 · AI · contact PI
USING INFORMATION TECHNOLOGY TO IMPROVE ASTHMA ADHERENCE$339,204
R01 · FY2007 · HL · contact PI
Mechanism of Endotoxin's Effect On Allergy Risk$670,530
R01 · FY2006 · AI · contact PI
USING INFORMATION TECHNOLOGY TO IMPROVE ASTHMA ADHERENCE$349,399
R01 · FY2006 · HL · contact PI
Mechanism of Endotoxin's Effect On Allergy Risk$713,713
R01 · FY2005 · AI
USING INFORMATION TECHNOLOGY TO IMPROVE ASTHMA ADHERENCE$357,870
R01 · FY2005 · HL
Mechanism of Endotoxin's Effect On Allergy Risk$329,588
R01 · FY2004 · AI